<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Lipoprotein(a) Information</title>
<style>
body {
    font-family: Arial, sans-serif;
    margin: 0;
    line-height: 1.6;
    background-color: #f7f9fb;
    color: #222;
}
header {
    background-color: #0b3d62;
    color: white;
    padding: 40px 20px;
    text-align: center;
}
section {
    max-width: 900px;
    margin: 40px auto;
    padding: 0 20px;
}
h1, h2 {
    color: #0b3d62;
}
footer {
    background-color: #0b3d62;
    color: white;
    text-align: center;
    padding: 20px;
    font-size: 0.9em;
}
.disclaimer {
    font-size: 0.9em;
    color: #555;
}
</style>
</head>

<body>

<header>
    <h1>Lipoprotein(a)</h1>
    <p>Medical Information for Patients</p>
</header>

<section>
    <h2>What is Lipoprotein(a)?</h2>
    <p>Lipoprotein(a), abbreviated Lp(a), is a genetically determined lipoprotein particle similar to LDL cholesterol. Elevated levels are associated with increased risk of atherosclerotic cardiovascular disease and aortic valve stenosis.</p>
</section>

<section>
    <h2>Why It Matters</h2>
    <p>High Lp(a) levels are an independent risk factor for cardiovascular disease. Unlike LDL cholesterol, Lp(a) levels are largely inherited and are not significantly affected by diet or lifestyle.</p>
</section>

<section>
    <h2>Who Should Be Tested?</h2>
    <ul>
        <li>Individuals with premature cardiovascular disease</li>
        <li>Family history of early heart disease</li>
        <li>Unexplained high LDL cholesterol</li>
        <li>Recurrent cardiovascular events despite standard therapy</li>
    </ul>
</section>

<section>
    <h2>How Is It Measured?</h2>
    <p>Lp(a) is measured with a blood test. Testing is generally recommended at least once in adulthood, particularly in individuals with cardiovascular risk factors.</p>
</section>

<section>
    <h2>Treatment Considerations</h2>
    <p>Currently, no widely approved therapies specifically lower Lp(a) significantly. Management focuses on aggressive control of other cardiovascular risk factors, including LDL cholesterol. Emerging therapies targeting Lp(a) are under clinical investigation.</p>
</section>

<section>
    <h2>Frequently Asked Questions</h2>
    <p><strong>Can diet lower Lp(a)?</strong><br>
    Lp(a) levels are primarily genetically determined and typically do not respond substantially to dietary modification.</p>

    <p><strong>How often should it be tested?</strong><br>
    In most individuals, Lp(a) testing is needed only once unless clinically indicated otherwise.</p>
</section>

<section>
    <h2>References</h2>
    <p>American Heart Association. Lipoprotein(a).<br>
    European Atherosclerosis Society Guidelines.</p>
</section>

<section class="disclaimer">
    <h2>Medical Disclaimer</h2>
    <p>This website is provided for informational purposes only and does not constitute medical advice. Patients should consult a qualified healthcare professional for diagnosis and treatment recommendations.</p>
</section>

<footer>
    Â© 2026 Lipoprotein(a) Information
</footer>

</body>
</html>
